Table 18 Anti-inflammatory screening results
From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | Paw oedema thickness (mm) | |||
|---|---|---|---|---|
120 m (X ± SE) | Oedema Inhibition (%) | 180 m (X ± SE) | Oedema Inhibition (%) | |
Control | 1.7 ± 0.03 | – | 1.8 ± 0.03 | – |
17a | 1.1 ± 0.03 | 41.1 | 1.0 ± 0.03 | 44.4 |
17b | 1.4 ± 0.03 | 17.6 | 1.5 ± 0.05 | 16.6 |
Nimesulide | 1.0 ± 0.00 | 41.1 | 1.1 ± 0.00 | 44.4 |